14-BROMODAUNORUBICIN HYDROCHLORIDE
UNII 78Y3VQG5K6

Substance Identification & Data

This profile provides standardized clinical and technical data for 14-bromodaunorubicin Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 78Y3VQG5K6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 29742-67-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
78Y3VQG5K6
CAS Registry Number
29742-67-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
14-BROMODAUNORUBICIN HYDROCHLORIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C27H28BrNO10.ClH
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
QOPOFAIJIBFJRD-RUELKSSGSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
10995837
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
Oc1c2c([C@@H](O[C@]3(C[C@H](N)[C@H](O)[C@H](C)O3)[H])C[C@@](C(CBr)=O)(O)C2)c(O)c4c1C(=O)c5c(C4=O)c(OC)ccc5.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 14-bromodaunorubicin Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

14-BROMODAUNOMYCIN HYDROCHLORIDE
14-BROMODAUNORUBICIN HYDROCHLORIDE

Systematic Nomenclature

5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-(2-BROMOACETYL)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, HYDROCHLORIDE (1:1), (8S,10S)-
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-(BROMOACETYL)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, HYDROCHLORIDE, (8S,10S)-
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-(BROMOACETYL)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, HYDROCHLORIDE, (8S-CIS)-
L-LYXO-HEXOPYRANOSIDE, 3-(BROMOACETYL)-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-, HYDROCHLORIDE, (1S,3S)-.ALPHA.-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound